Free Trial

Vaxcyte (PCVX) Earnings Date, Estimates & Call Transcripts

Vaxcyte logo
$86.53 +0.32 (+0.37%)
(As of 12/20/2024 05:31 PM ET)

Vaxcyte Latest Earnings Summary

Actual EPS
(Nov. 5)
-$0.83 Beat By $0.27
Consensus EPS
(Nov. 5)
-$1.10

Vaxcyte released Q3 2024 earnings on November 5, 2024, reporting an EPS of -$0.83, which beat analysts' consensus estimates of -$1.10 by $0.27. With a trailing EPS of -$4.60, Vaxcyte's earnings are expected to decrease next year, from ($4.14) to ($4.49) per share.

Get Vaxcyte Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vaxcyte and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

PCVX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PCVX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Vaxcyte Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$1.00-$0.80-$0.90
Q2 20242-$1.00-$0.86-$0.93
Q3 20242-$0.88-$0.79-$0.84
Q4 20242-$0.91-$0.78-$0.85
FY 20248($3.79)($3.23)($3.51)

Vaxcyte Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/5/2024Q3 2024-$1.10-$0.83+$0.27-$0.83--
8/6/2024Q2 2024-$1.14-$1.10+$0.04-$1.10--
5/8/2024Q1 2024-$1.13-$0.85+$0.28-$0.85--
2/27/2024Q4 2023-$0.89-$1.82 -$0.93-$1.82--
11/6/2023Q3 2023-$0.84-$0.91 -$0.07-$0.91--
8/8/2023Q2 2023-$0.74-$0.70+$0.04-$0.70--
This is the worst sign for the U.S. stock market in 50 years (Ad)

The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone"

Click here to see Dan's new, urgent warning about the U.S. market for 2025.
5/8/2023Q1 2023-$0.80-$0.70+$0.10-$0.70--
2/27/2023Q4 2022-$0.84-$0.73+$0.11-$0.43--

Vaxcyte Earnings - Frequently Asked Questions

Vaxcyte (NASDAQ:PCVX) last announced its quarterly earning data on Tuesday, November 5, 2024. Learn more on PCVX's earnings history.

In the previous quarter, Vaxcyte (NASDAQ:PCVX) reported ($0.83) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.10) by $0.27. Learn more on analysts' earnings estimate vs. PCVX's actual earnings.

Vaxcyte (NASDAQ:PCVX) has a recorded net income of -$402.27 million. PCVX has generated -$4.60 earnings per share over the last four quarters.

Vaxcyte's earnings are expected to decrease from ($4.14) per share to ($4.49) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:PCVX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners